Search research articles
Contact Us
Filters
Showing results (121-130 of 177) with videos related to
Page
of 18
Sort By:
The American Journal of the Medical Sciences
|
June 1, 1971
Oral urea and the prophylactic treatment of sickle cell disease--a preliminary report
R M Nalbandian, J W Anderson, J M Lusher, et al.
Pediatric Blood & Cancer
|
November 30, 2012
Emergency department visits in children with hemophilia
Bülent Özgönenel, Ayesha Zia, Michael U Callaghan, et al.
Veterinary Microbiology
|
July 1, 1990
Characterisation of Chlamydia psittaci isolated from a horse
J M Wills, G Watson, M Lusher, et al.
JAMA
|
June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy
G F Pierce, J M Lusher, A P Brownstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 26, 2000
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia
M V Ragni, J M Lusher, M A Koerper, et al.
British Journal of Haematology
|
May 22, 2008
Thromboelastography in children with coagulation factor deficiencies
Meera Chitlur, Indira Warrier, Madhvi Rajpurkar, et al.
Pediatric Blood & Cancer
|
May 22, 2008
Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia
Zhihong J Wang, Nkechi Onwuzurike, Michael U Callaghan, et al.
JAMA
|
December 13, 1971
Sickledex test for hemoglobin S. A critique
R M Nalbandian, N L Henry, J M Lusher, et al.
Thrombosis and Haemostasis
|
April 20, 2001
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis
G C White, F Rosendaal, L M Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 24, 1999
Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group
S Seremetis, J M Lusher, C F Abildgaard, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 177) with videos related to
Sort By:
Page
of 18
The American Journal of the Medical Sciences
|
June 1, 1971
Oral urea and the prophylactic treatment of sickle cell disease--a preliminary report
R M Nalbandian, J W Anderson, J M Lusher, et al.
Pediatric Blood & Cancer
|
November 30, 2012
Emergency department visits in children with hemophilia
Bülent Özgönenel, Ayesha Zia, Michael U Callaghan, et al.
Veterinary Microbiology
|
July 1, 1990
Characterisation of Chlamydia psittaci isolated from a horse
J M Wills, G Watson, M Lusher, et al.
JAMA
|
June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy
G F Pierce, J M Lusher, A P Brownstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 26, 2000
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia
M V Ragni, J M Lusher, M A Koerper, et al.
British Journal of Haematology
|
May 22, 2008
Thromboelastography in children with coagulation factor deficiencies
Meera Chitlur, Indira Warrier, Madhvi Rajpurkar, et al.
Pediatric Blood & Cancer
|
May 22, 2008
Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia
Zhihong J Wang, Nkechi Onwuzurike, Michael U Callaghan, et al.
JAMA
|
December 13, 1971
Sickledex test for hemoglobin S. A critique
R M Nalbandian, N L Henry, J M Lusher, et al.
Thrombosis and Haemostasis
|
April 20, 2001
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis
G C White, F Rosendaal, L M Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 24, 1999
Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group
S Seremetis, J M Lusher, C F Abildgaard, et al.
Page
of 18